182 related articles for article (PubMed ID: 3227914)
41. Sympathetic vascular control of the pig nasal mucosa: adrenoceptor mechanisms in blood flow and volume control.
Lacroix JS; Lundberg JM
Br J Pharmacol; 1989 Aug; 97(4):1075-84. PubMed ID: 2529015
[TBL] [Abstract][Full Text] [Related]
42. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.
Lundberg JM; Franco-Cereceda A; Hemsén A; Lacroix JS; Pernow J
Fundam Clin Pharmacol; 1990; 4(4):373-91. PubMed ID: 2170253
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
Lundberg JM; Rudehill A; Sollevi A
Eur J Pharmacol; 1989 Apr; 163(1):103-13. PubMed ID: 2744085
[TBL] [Abstract][Full Text] [Related]
45. Sensory neuropeptides and nitric oxide in nasal vascular regulation.
Rinder J
Acta Physiol Scand Suppl; 1996; 632():1-45. PubMed ID: 8800374
[TBL] [Abstract][Full Text] [Related]
46. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
[TBL] [Abstract][Full Text] [Related]
48. Neuropeptide Y and sympathetic neurotransmission.
Lundberg JM; Franco-Cereceda A; Lacroix JS; Pernow J
Ann N Y Acad Sci; 1990; 611():166-74. PubMed ID: 2174218
[TBL] [Abstract][Full Text] [Related]
49. Effects of cervical sympathetic nerve stimulation and neuropeptide Y (NPY) on cranial blood flow in the cat.
Granstam E; Nilsson SF
Acta Physiol Scand; 1991 May; 142(1):21-32. PubMed ID: 1877362
[TBL] [Abstract][Full Text] [Related]
50. Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs.
McCloskey MJ; Potter EK
Auton Neurosci; 2000 Oct; 84(1-2):50-7. PubMed ID: 11109989
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms involved in colonic vasoconstriction and inhibition of motility induced by neuropeptide Y.
Hellström PM
Acta Physiol Scand; 1987 Apr; 129(4):549-56. PubMed ID: 3591377
[TBL] [Abstract][Full Text] [Related]
52. NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation?
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E; Anggård A
Acta Physiol Scand; 1986 Jan; 126(1):151-2. PubMed ID: 3754082
[No Abstract] [Full Text] [Related]
53. Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose.
Cervin A; Onnerfält J; Edvinsson L; Grundemar L
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1724-8. PubMed ID: 10556147
[TBL] [Abstract][Full Text] [Related]
54. Nitric oxide inhibition of renal vasoconstrictor responses to sympathetic cotransmitters in the pig in vivo.
Malmström RE; Björne H; Alving K; Weitzberg E; Lundberg JO
Nitric Oxide; 2001 Apr; 5(2):98-104. PubMed ID: 11292359
[TBL] [Abstract][Full Text] [Related]
55. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
Pernow J; Thorén P; Millberg BI; Lundberg JM
Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
[TBL] [Abstract][Full Text] [Related]
56. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.
Lundberg JM; Hua XY; Franco-Cereceda A
Acta Physiol Scand; 1984 Aug; 121(4):325-32. PubMed ID: 6091417
[TBL] [Abstract][Full Text] [Related]
57. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.
Lundberg JM; Al-Saffar A; Saria A; Theodorsson-Norheim E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):163-8. PubMed ID: 3010140
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
59. Effect of catecholamine depletion and denervation on neuropeptide Y(NPY) and tyrosine-hydroxylase (TH) mRNA levels in rat sympathetic ganglia.
Hänze J; Kummer W; Haass M; Lang RE
Exp Clin Endocrinol; 1994; 102(1):54-9. PubMed ID: 7911764
[TBL] [Abstract][Full Text] [Related]
60. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
